First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.08 CNY 0.82% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 46.28 CNY. Compared to the current market price of 32.08 CNY, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
46.28 CNY
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
66
vs Industry
79
Median 3Y
0.7
Median 5Y
0.7
Industry
2.4
Forward
0.6
More Details
12.9
P/E
P/E
Price to Earnings
12.9
vs History
63
vs Industry
35
Median 3Y
12.7
Median 5Y
13.3
Industry
22.9
Forward
14.8
More Details
12.7
P/OCF
P/OCF
Price to OCF
12.7
vs History
33
vs Industry
31
Median 3Y
10.1
Median 5Y
11.1
Industry
17.1
More Details
19.3
P/FCFE
P/FCFE
Price to FCFE
19.3
vs History
14
vs Industry
23
Median 3Y
13
Median 5Y
13.9
Industry
23.2
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
80
vs Industry
50
Median 3Y
1.6
Median 5Y
1.7
Industry
2.1
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
50
vs Industry
81
Median 3Y
0.6
Median 5Y
0.6
Industry
2.6
Forward
0.6
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
57
vs Industry
59
Median 3Y
3.1
Median 5Y
3.5
Industry
5.1
More Details
10
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10
vs History
49
vs Industry
35
Median 3Y
9.3
Median 5Y
10
Industry
13.6
Forward
7.7
More Details
10
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10
vs History
49
vs Industry
39
Median 3Y
9.3
Median 5Y
10
Industry
17
Forward
9.1
More Details
11.5
EV/OCF
EV/OCF
Enterprise Value to OCF
11.5
vs History
31
vs Industry
35
Median 3Y
8
Median 5Y
9.6
Industry
15.8
More Details
19.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.1
vs History
30
vs Industry
22
Median 3Y
10.5
Median 5Y
15.6
Industry
17.6
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
87
vs Industry
58
Median 3Y
1.1
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
52.2B CNY 0.7 12.9 10 10
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
697.9B USD 20.5 133.2 60.2 69.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.3 45.2 33 36
US
Johnson & Johnson
NYSE:JNJ
357.8B USD 4.4 8.8 11.8 15.5
US
Merck & Co Inc
NYSE:MRK
323.8B USD 5.3 140.4 33.4 53
UK
AstraZeneca PLC
LSE:AZN
186.8B GBP 5.1 39.4 140.7 225.6
CH
Novartis AG
SIX:NOVN
179.8B CHF 4.3 13.4 9.8 16.2
CH
Roche Holding AG
SIX:ROG
173.2B CHF 3 15.1 8.6 10.2
US
Pfizer Inc
NYSE:PFE
155.7B USD 2.7 73.5 11 16.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.